Cairncross, J. G., Wang, M., Jenkins, R. B., Shaw, E. G., Giannini, C., Brachman, D. G., . . . Curran, W. J. (2014). Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH. American Society of Clinical Oncology.
Citação norma ChicagoCairncross, J. Gregory, et al. Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH. American Society of Clinical Oncology, 2014.
MLA CitationCairncross, J. Gregory, et al. Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH. American Society of Clinical Oncology, 2014.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.